Zobrazeno 1 - 10
of 66
pro vyhledávání: '"Mariana Pavel"'
Autor:
Laura Iulia Grecu, Mariana Pavel-Tanasa, Lilia Matei, Camelia Sultana, Simona Maria Ruta, Razvan Ioan Grecu, Ramona Gabriela Ursu, Petru Cianga, Luminita Smaranda Iancu
Publikováno v:
Pathogens, Vol 13, Iss 9, p 793 (2024)
The hepatitis D virus (HDV) superinfection of individuals with chronic hepatitis B virus (HBV) infection causes severe liver damage and the poorest long-term prognosis among viral hepatitis. This is attributed to the unique pathogenic mechanisms of H
Externí odkaz:
https://doaj.org/article/3d98f8080cf049be8548e03bfb860de0
Autor:
Cristina Georgiana Croitoru, Mariana Pavel-Tanasa, Dan Iulian Cuciureanu, Diana Nicoleta Hodorog, Petru Cianga
Publikováno v:
Journal of Clinical Medicine, Vol 13, Iss 8, p 2273 (2024)
Background: As the life expectancy of patients with myasthenia gravis (MG) is improving, so the number of comorbidities continues to rise, with a potentially significant impact on the overall morbidity and mortality. The main aim of the study was to
Externí odkaz:
https://doaj.org/article/955598c174e24c2f834da8c414fd4be4
Autor:
Tudorita Gabriela Paranga, Mariana Pavel-Tanasa, Daniela Constantinescu, Claudia Elena Plesca, Cristina Petrovici, Ionela-Larisa Miftode, Mihaela Moscalu, Petru Cianga, Egidia Gabriela Miftode
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
C-reactive protein (CRP) has been one of the most investigated inflammatory-biomarkers during the ongoing COVID-19 pandemics caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). The severe outcome among patients with SARS-CoV-2 inf
Externí odkaz:
https://doaj.org/article/aba437d689c34f0bb72a89073dc686f7
Autor:
Diana Cornelia Moisuc, Daniela Constantinescu, Mihai Vasile Marinca, Bogdan Gafton, Mariana Pavel-Tanasa, Petru Cianga
Publikováno v:
Cancers, Vol 16, Iss 2, p 385 (2024)
Colorectal cancer (CRC) ranks as second most common cause of cancer-related deaths. The CRC management considerably improved in recent years, especially due to biological therapies such as bevacizumab. The lack of predictive or prognostic biomarkers
Externí odkaz:
https://doaj.org/article/25dbe9fa7f744f079a725a524b76caaa
Autor:
Laura Iulia Grecu, Camelia Sultana, Mariana Pavel-Tanasa, Simona Maria Ruta, Mihaela Chivu-Economescu, Lilia Matei, Ramona Gabriela Ursu, Elena Iftimi, Luminita Smaranda Iancu
Publikováno v:
Microorganisms, Vol 11, Iss 12, p 2895 (2023)
Approximately 62–72 million people are infected worldwide with HDV. Patients with chronic hepatitis D (CHD) have a higher risk of developing cirrhosis or hepatocellular carcinoma (HCC) and an increased mortality rate compared to those with chronic
Externí odkaz:
https://doaj.org/article/7872b187b40d41259c5f65f6e32c9566
Autor:
Diana Cornelia Moisuc, Mihai Vasile Marinca, Bogdan Gafton, Teodora Alexa-Stratulat, Mariana Pavel-Tanasa, Petru Cianga
Publikováno v:
Current Oncology, Vol 29, Iss 6, Pp 3996-4011 (2022)
Treatment with bevacizumab is known to cause adverse events such as proteinuria and hypertension, amongst others. However, while bevacizumab-induced hypertension has been linked to increased overall survival (OS), data on proteinuria are controversia
Externí odkaz:
https://doaj.org/article/4d79541a3cd94ae5bdfaf4367810b88b
Autor:
Vlad Andrei Cianga, Cristina Rusu, Mariana Pavel-Tanasa, Angela Dascalescu, Catalin Danaila, Sebastian Harnau, Carmen-Mariana Aanei, Petru Cianga
Publikováno v:
Frontiers in Medicine, Vol 10 (2023)
IntroductionNatural killer (NK) cells are key anti-tumor effectors of the innate immunity. Phenotypic differences allow us to discriminate in between three functional stages of maturation, named immature, mature and hypermature that are distinctive i
Externí odkaz:
https://doaj.org/article/fda948deb3b44ddf9e83d704cf612f63
Autor:
Mariana Pavel-Tanasa, Daniela Constantinescu, Corina Maria Cianga, Ecaterina Anisie, Ana Irina Mereuta, Cristina Gabriela Tuchilus, Petru Cianga
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) led to a global health outbreak known as the COVID-19 pandemic which has been lasting since March 2020. Vaccine became accessible to people only at the beginning of 2021 which greatly helpe
Externí odkaz:
https://doaj.org/article/496e1eedf2574327ae99d121fcf92072
Autor:
Mariana Pavel, So Jung Park, Rebecca A. Frake, Sung Min Son, Marco M. Manni, Carla F. Bento, Maurizio Renna, Thomas Ricketts, Fiona M. Menzies, Radu Tanasa, David C. Rubinsztein
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-21 (2021)
Autophagy regulates multiple pathways including YAP/TAZ of the Hippo pathway, but precise mechanisms are unclear as autophagy may either activate or inhibit YAP/TAZ. Here, the authors show that autophagy can either activate or regulate YAP/TAZ via dy
Externí odkaz:
https://doaj.org/article/d02b9e5043ae49d9b06eb7b9936822b7
Autor:
Felicia Trofin, Olivia Simona Dorneanu, Daniela Constantinescu, Eduard Vasile Nastase, Cătălina Luncă, Luminița Smaranda Iancu, Ioana-Maria Andrioaie, Alexandru Duhaniuc, Corina Maria Cianga, Mariana Pavel-Tanasa, Dana-Teodora Anton-Păduraru, Petru Cianga
Publikováno v:
Vaccines, Vol 10, Iss 12, p 2001 (2022)
Introduction: The COVID-19 disease and anti-SARS-CoV-2 vaccination were accompanied by alterations in several inflammatory markers. The aim of our research was to check to what extent such cytokines are transferred to infants via the breastmilk of SA
Externí odkaz:
https://doaj.org/article/b28e51305da94ebb8aab14279a2534a1